Enlivex Therapeutics Ltd. (ENLV.TA)

ILA 330.6

(-0.57%)

Inventory Summary of Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd.'s latest annual inventory in 2023 was -229 Thousand USD , down -106.43% from previous year.
Enlivex Therapeutics Ltd.'s latest quarterly inventory in 2024 Q2 was 1.14 Million USD , up 100.0% from previous quarter.
Enlivex Therapeutics Ltd. reported annual inventory of 3.55 Million USD in 2022, up 3116.17% from previous year.
Enlivex Therapeutics Ltd. reported annual inventory of 110.68 Thousand USD in 2021, down -91.13% from previous year.
Enlivex Therapeutics Ltd. reported quarterly inventory of -3.81 Million USD for 2024 Q1, down -161.45% from previous quarter.
Enlivex Therapeutics Ltd. reported quarterly inventory of -229 Thousand USD for 2023 FY, down -106.43% from previous quarter.

Annual Inventory Chart of Enlivex Therapeutics Ltd. (2023 - 2012)

Historical Annual Inventory of Enlivex Therapeutics Ltd. (2023 - 2012)

Year	Inventory	Inventory Growth
2023	-229 Thousand USD	-106.43%
2022	3.55 Million USD	3116.17%
2021	110.68 Thousand USD	-91.13%
2020	1.24 Million USD	-37.79%
2019	2 Million USD	597.6%
2018	287.49 Thousand USD	323.47%
2017	67.89 Thousand USD	0.0%
2016	- USD	0.0%
2015	- USD	0.0%
2014	- USD	0.0%
2013	- USD	0.0%
2012	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.14 Million USD	100.0%
2024 Q1	-3.81 Million USD	-161.45%
2023 FY	-229 Thousand USD	-106.43%
2023 Q1	-1604.00 USD	-100.05%
2023 Q4	6.2 Million USD	462390.1%
2023 Q3	-1343.00 USD	28.72%
2023 Q2	-1884.00 USD	-17.46%
2022 Q3	19.21 Million USD	17299.01%
2022 Q4	3.55 Million USD	-81.47%
2022 FY	3.55 Million USD	3116.17%
2022 Q1	111.7 Thousand USD	0.92%
2022 Q2	110.43 Thousand USD	-1.14%
2021 Q2	880.77 Thousand USD	-27.98%
2021 FY	110.68 Thousand USD	-91.13%
2021 Q1	1.22 Million USD	-1.98%
2021 Q4	110.68 Thousand USD	-87.3%
2021 Q3	871.34 Thousand USD	-1.07%
2020 Q2	3.37 Million USD	0.53%
2020 FY	1.24 Million USD	-37.79%
2020 Q3	2.7 Million USD	-19.67%
2020 Q4	1.24 Million USD	-53.96%
2020 Q1	3.35 Million USD	67.29%
2019 Q3	2.15 Million USD	191.79%
2019 FY	2 Million USD	597.6%
2019 Q4	2 Million USD	-6.86%
2019 Q2	738 Thousand USD	46.43%
2019 Q1	504 Thousand USD	75.3%
2018 Q2	- USD	0.0%
2018 Q3	- USD	0.0%
2018 Q4	287.49 Thousand USD	0.0%
2018 FY	287.49 Thousand USD	323.47%
2018 Q1	- USD	-100.0%
2017 FY	67.89 Thousand USD	0.0%
2017 Q3	- USD	0.0%
2017 Q4	67.89 Thousand USD	0.0%
2017 Q1	- USD	0.0%
2017 Q2	- USD	0.0%
2016 Q3	- USD	0.0%
2016 Q2	- USD	0.0%
2016 Q1	- USD	0.0%
2016 FY	- USD	0.0%
2016 Q4	- USD	0.0%
2015 Q3	- USD	0.0%
2015 Q4	- USD	0.0%
2015 FY	- USD	0.0%
2015 Q2	- USD	0.0%
2015 Q1	- USD	0.0%
2014 Q4	- USD	0.0%
2014 Q3	- USD	0.0%
2014 Q2	- USD	0.0%
2014 FY	- USD	0.0%
2013 Q4	- USD	0.0%
2013 FY	- USD	0.0%
2012 FY	- USD	0.0%

Peer Inventory Comparison of Enlivex Therapeutics Ltd.

Name	Inventory	Inventory Difference
Matricelf Ltd	- ILA	Infinity%